LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 78 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,346,861 | -1.9% | 916,232 | +112.1% | 0.00% | 0.0% |
| Q2 2023 | $1,373,493 | +223.9% | 431,916 | +140.4% | 0.00% | +100.0% |
| Q1 2023 | $424,066 | -32.0% | 179,689 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $623,521 | -53.2% | 179,689 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $1,331,000 | +13.6% | 179,689 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $1,172,000 | +29.2% | 179,689 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $907,000 | -30.6% | 179,689 | +6.5% | 0.00% | 0.0% |
| Q4 2021 | $1,306,000 | -21.7% | 168,689 | +49.8% | 0.00% | -50.0% |
| Q3 2021 | $1,667,000 | +32.9% | 112,640 | +30.2% | 0.00% | +100.0% |
| Q2 2021 | $1,254,000 | – | 86,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $131,458,000 | 59.13% |
| Apoletto Ltd | 15,093,969 | $98,413,000 | 27.22% |
| Foresite Capital Management IV, LLC | 13,282,181 | $86,600,000 | 23.32% |
| MIC Capital Management UK LLP | 3,060,569 | $19,955,000 | 3.90% |
| Alphabet Inc. | 5,865,125 | $38,241,000 | 2.08% |
| HSG Holding Ltd | 3,045,997 | $19,860,000 | 1.83% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $10,744,000 | 0.72% |
| SG3 Management, LLC | 600,000 | $3,912,000 | 0.46% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 157,700 | $1,028,000 | 0.26% |
| Artal Group S.A. | 700,000 | $4,564,000 | 0.24% |